[ Price : $8.95]
Federal Register notice: FDA announces it is revoking approval of an Eli Lilly BLA for Lartruvo (olaratumab), indicated for combin...[ Price : $8.95]
FDA sends a Warning Letter to the operators of www.pharmaboosters.com over marketing unapproved and misbranded drugs.[ Price : $8.95]
FDA clears an Ambu 510(k) for its Ambu aScope Duodeno, a single-use duodenoscope.[ Price : $8.95]
FDA grants Denovo Biopharma a fast track designation for DB102 (enzastaurin) and its use as a potential treatment for patients wit...[ Price : $8.95]
FDA authorizes the de novo marketing of Tandem Diabetes Cares Control-IQ Technology, an interoperable automated glycemic controlle...[ Price : $8.95]
Federal Register notice: FDA issues a final rule to repeal a regulation that required an FDA-approved NDA or ANDA for any drug pro...[ Price : $8.95]
FDA clears a Boston Scientific 510(k) for its Exalt Model D Single-Use Duodenoscope.[ Price : $8.95]
FDA releases a draft guidance on Qualification Process for Drug Development Tools Guidance for Industry and FDA Staff.